Susquehanna International Group, LLP Essa Pharma Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	SELL	$6.17 - $10.65 $19,127 - $33,015	-3,100 Reduced 16.49%	15,700 $133,000
Q4 2023 Feb 14, 2024	SELL	$2.74 - $7.35 $50,690 - $135,975	-18,500 Reduced 49.6%	18,800 $124,000
Q3 2023 Nov 14, 2023	BUY	$2.65 - $3.31 $53,795 - $67,193	20,300 Added 119.41%	37,300 $115,000
Q2 2023 Aug 11, 2023	SELL	$2.6 - $3.34 $179,400 - $230,460	-69,000 Reduced 80.23%	17,000 $45,000
Q1 2023 May 16, 2023	BUY	$2.56 - $3.55 $107,264 - $148,745	41,900 Added 95.01%	86,000 $255,000
Q4 2022 Feb 14, 2023	BUY	$1.5 - $4.82 $66,150 - $212,562	44,100 New	44,100 $111,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $78.9M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.